Congress Passes The Families First Coronavirus Response Act
March 19, 2020 On March 18th, the President signed the Families First Coronavirus Response Act (H.R. 6201) – a legislative…
What’s the Difference Between COVID-19 and the Flu?
Early on in the outbreak of COVID-19, comparisons to the flu — from symptoms to mortality rate and potential impact —…
Stuart Schlossman
GENENTECH INITIATES PHASE III CLINICAL TRIAL OF ACTEMRA IN HOSPITALIZED PATIENTS WITH SEVERE COVID-19 PNEUMONIA
Genentech is working with the U.S. Food & Drug Administration (FDA) to initiate a randomized, double-blind, placebo-controlled Phase III clinical trial in collaboration…
Stuart Schlossman
Guidance for the use of disease modifying therapies during the COVID-19 pandemic
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There…
Stuart Schlossman
